Jenkem Technology Co Ltd (688356) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Jenkem Technology Co Ltd (688356) has a cash flow conversion efficiency ratio of -0.013x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-16.46 Million ≈ $-2.41 Million USD) by net assets (CN¥1.30 Billion ≈ $189.92 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Jenkem Technology Co Ltd - Cash Flow Conversion Efficiency Trend (2016–2024)
This chart illustrates how Jenkem Technology Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Jenkem Technology Co Ltd (688356) financial obligations for a breakdown of total debt and financial obligations.
Jenkem Technology Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Jenkem Technology Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Shanghai Shuixing Home Textile Co Ltd Class A
SHG:603365
|
0.000x |
|
Vanjee Technology Co Ltd
SHE:300552
|
0.001x |
|
Satrec Initiative Co. Ltd
KQ:099320
|
0.004x |
|
Zhangjiagang Guangda Special Material Co Ltd
SHG:688186
|
-0.021x |
|
Guangdong Insight Brand Marketing Group Co Ltd
SHE:300781
|
0.005x |
|
Beijing WKW Automotive Parts Co Ltd
SHE:002662
|
0.036x |
|
Integra LifeSciences Holdings
NASDAQ:IART
|
0.039x |
|
Omeros Corporation
NASDAQ:OMER
|
0.084x |
Annual Cash Flow Conversion Efficiency for Jenkem Technology Co Ltd (2016–2024)
The table below shows the annual cash flow conversion efficiency of Jenkem Technology Co Ltd from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see market value of Jenkem Technology Co Ltd.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥1.27 Billion ≈ $185.37 Million |
CN¥120.18 Million ≈ $17.59 Million |
0.095x | +1.37% |
| 2023-12-31 | CN¥1.28 Billion ≈ $187.32 Million |
CN¥119.81 Million ≈ $17.53 Million |
0.094x | -38.33% |
| 2022-12-31 | CN¥1.22 Billion ≈ $179.22 Million |
CN¥185.86 Million ≈ $27.20 Million |
0.152x | +34.97% |
| 2021-12-31 | CN¥1.05 Billion ≈ $153.89 Million |
CN¥118.23 Million ≈ $17.30 Million |
0.112x | +23.07% |
| 2020-12-31 | CN¥856.24 Million ≈ $125.30 Million |
CN¥78.22 Million ≈ $11.45 Million |
0.091x | -60.53% |
| 2019-12-31 | CN¥220.35 Million ≈ $32.24 Million |
CN¥51.00 Million ≈ $7.46 Million |
0.231x | +15.95% |
| 2018-12-31 | CN¥168.70 Million ≈ $24.69 Million |
CN¥33.68 Million ≈ $4.93 Million |
0.200x | +30.63% |
| 2017-12-31 | CN¥139.70 Million ≈ $20.44 Million |
CN¥21.35 Million ≈ $3.12 Million |
0.153x | +25.56% |
| 2016-12-31 | CN¥122.81 Million ≈ $17.97 Million |
CN¥14.95 Million ≈ $2.19 Million |
0.122x | -- |
About Jenkem Technology Co Ltd
Jenkem Technology Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of medical and pharmaceutical polyethylene glycol derivative (PEG) products in China and internationally. The company offers high molecular weight polyethylene glycol derivatives comprising branched, methoxylated, bifunctionalized, heterofunctionalized disubstituted, multi-arm, … Read more